Abstract: A pharmaceutical container may include a cylindrical hollow container body (100) defining a hollow chamber (111) to receive a pharmaceutical liquid, the container body (100) including a portion on a sidewall (121) of the container body (100), wherein the portion has a longitudinal extension along the longitudinal axis of the container body (100) and a circumferential extension along the circumference of the container body (100), thereby forming a window (122) through the sidewall (121) of the container body (100) into the hollow chamber (111), the window (122) comprising two long edges (124) and two short edges (125), and a Near Field Communication (NFC) antenna (110) arranged on the outer surface (120) of the sidewall (121) of the container, the antenna (110) including one or a plurality of nested antenna windings (150), each of them surrounding an interior periphery (140) including a substantially longitudinal portion (141) arranged along the two long edges (124) of the window (122), and a substantially cir

Abstract: A pharmaceutical container may include a cylindrical hollow container body (100) defining a hollow chamber (111) to receive a pharmaceutical liquid, the container body (100) including a portion on a sidewall (121) of the container body (100), wherein the portion has a longitudinal extension along the longitudinal axis of the container body (100) and a circumferential extension along the circumference of the container body (100), thereby forming a window (122) through the sidewall (121) of the container body (100) into the hollow chamber (111), the window (122) comprising two long edges (124) and two short edges (125), and a Near Field Communication (NFC) antenna (110) arranged on the outer surface (120) of the sidewall (121) of the container, the antenna (110) including one or a plurality of nested antenna windings (150), each of them surrounding an interior periphery (140) including a substantially longitudinal portion (141) arranged along the two long edges (124) of the window (122), and a substantially cir

Abstract: A pharmaceutical container includes a cylindrical hollow container body defining a hollow chamber to receive a pharmaceutical liquid, the container body including a portion on a sidewall) of the container body, wherein the portion has a longitudinal extension along the longitudinal axis of the container body and a circumferential extension along the circumference of the container body, thereby forming a window through the sidewall of the container body into the hollow chamber. In embodiments of the invention, the window comprises two long edges and two short edges, and a Near Field Communication (NFC) antenna. In embodiments of the invention, the antenna comprises one or a plurality of nested antenna windings.

Abstract: A pharmaceutical container may include a cylindrical hollow container body (100) defining a hollow chamber (111) to receive a pharmaceutical liquid, the container body (100) including a portion on a sidewall (121) of the container body (100), wherein the portion has a longitudinal extension along the longitudinal axis of the container body (100) and a circumferential extension along the circumference of the container body (100), thereby forming a window (122) through the sidewall (121) of the container body (100) into the hollow chamber (111), the window (122) comprising two long edges (124) and two short edges (125), and a Near Field Communication (NFC) antenna (110) arranged on the outer surface (120) of the sidewall (121) of the container, the antenna (110) including one or a plurality of nested antenna windings (150), each of them surrounding an interior periphery (140) including a substantially longitudinal portion (141) arranged along the two long edges (124) of the window (122), and a substantially cir

Abstract: Particulate embolotherapeutic compositions are described in which the particles comprise a matrix polymer expressing at surfaces available for interaction with biological molecules or, usually, blood cells, express zwitterionic groups, usually phosphoryl choline groups. The particles have suitable size and compressibility, for instance controlled by controlling the water content, for use in embolotherapy, by administration using catheters or hypodermic needles. The matrix polymer may be crosslinked. Preferably the particles are spherical. Examples are crosslinked polyvinylalcohol matrices coated with a crosslinkable copolymer formed of 2-methacryloyloxyethyl-2?-trimethylammoniumethyl phosphate inner salt with nonionic and crosslinkable comonomers. The coating is stabilised by crosslinking after coating from an organic solvent solution.

Abstract: A computer-implemented method for installing a computer program from a removable data storage device using disk-mirroring techniques. The method includes the steps of mounting a removable data storage device containing the computer program as a read-only half of a mirrored logical volume identifying a fixed data storage device or hard disk drive as a read-write half of the mirrored logical volume; synchronizing the two halves of the mirrored logical volume by copying data from the removable data storage device to the hard drive; executing the computer program from the mirrored logical volume after an initial portion of the data is copied from the removable data storage device to the hard drive by the synchronization step and prior to a completion of the synchronization step; and removing the removable data storage device after the synchronization step is completed, thereby un-mirroring the logical volume. The removable data storage device may be a CD-ROM drive, floppy disk drive or tape drive.